TVRD
Tvardi Therapeutics
TVRD
TVRD
134 hedge funds and large institutions have $315M invested in Tvardi Therapeutics in 2018 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 46 increasing their positions, 35 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
26% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 31
44% less capital invested
Capital invested by funds: $563M → $315M (-$248M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
134
Holding in Top 10
2
Calls
$4.34M
Puts
$5.68M
Top Buyers
| 1 | +$7.62M | |
| 2 | +$5.37M | |
| 3 | +$3.64M | |
| 4 |
Citigroup
New York
|
+$2.7M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.81M |
Top Sellers
| 1 | -$17.7M | |
| 2 | -$3.11M | |
| 3 | -$2.04M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.82M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1.56M |